LONDON/COPENHAGEN (Reuters) -Shares in Novo Nordisk fell as much as 3.5% on Monday after detailed trial data on its ...

DoseSpot CEO Josh Weiner points out that a $10.2M savings across 100K+ prescriptions in 3 months extrapolated out across the 32.8M Americans currently taking GLP-1 medication monthly indicates a ...